Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia
- PMID: 2990687
Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia
Abstract
Interleukin-2 (IL-2) is a lymphokine synthesized by some T-cells following activation. Resting T-cells do not express IL-2 receptors, but receptors are rapidly expressed on T-cells following interaction of antigens, mitogens, or monoclonal antibodies with the antigen-specific T-cell receptor complex. Using anti-Tac, a monoclonal antibody that recognizes the IL-2 receptor, the receptor has been purified and shown to be a Mr 33,000 peptide that is posttranslationally glycosylated to a Mr 55,000 mature form. Normal resting T-cells and most leukemic T-cell populations do not express IL-2 receptors; however, the leukemic cells of the 11 patients examined who had human T-cell lymphotropic virus-associated adult T-cell leukemia expressed the Tac antigen. In human T-cell lymphotropic virus-I infected cells, the Mr 42,000 long open reading frame protein encoded in part by the pX region of this virus may act as a transacting transcriptional activator that induces IL-2 receptor gene transcription, thus providing an explanation for the constant association of IL-2 receptor expression with adult T-cell lymphotropic virus-I infection of lymphoid cells. The constant expression of large numbers of IL-2 receptors which may be aberrant may play a role in the uncontrolled growth of adult T-cell leukemia cells. Two patients with Tac-positive adult T-cell leukemia have been treated with the anti-Tac. One of the patients had 6- and 3-mo remissions of his leukemia following two courses of therapy with this monoclonal antibody directed toward this growth factor receptor.
Similar articles
-
Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.Princess Takamatsu Symp. 1984;15:259-68. Princess Takamatsu Symp. 1984. PMID: 6100644
-
The arrangement of immunoglobulin, T cell antigen receptor, and interleukin 2 receptor genes in human lymphoid neoplasms.Symp Fundam Cancer Res. 1986;38:63-78. Symp Fundam Cancer Res. 1986. PMID: 3489263
-
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.Prog Clin Biol Res. 1988;262:283-93. Prog Clin Biol Res. 1988. PMID: 2897696
-
IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.Cancer Surv. 1989;8(4):891-903. Cancer Surv. 1989. PMID: 2701734 Review.
-
The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):45-53. Am J Kidney Dis. 1989. PMID: 2683757 Review.
Cited by
-
HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.Apoptosis. 2008 Jun;13(6):733-47. doi: 10.1007/s10495-008-0208-7. Apoptosis. 2008. PMID: 18421579 Free PMC article. Review.
-
The Potential Role of a Soluble γ-Chain Cytokine Receptor as a Regulator of IL-7-Induced Lymphoproliferative Disorders.Int J Mol Sci. 2018 Oct 28;19(11):3375. doi: 10.3390/ijms19113375. Int J Mol Sci. 2018. PMID: 30373315 Free PMC article.
-
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.Ther Adv Neurol Disord. 2014 Jan;7(1):7-21. doi: 10.1177/1756285613504021. Ther Adv Neurol Disord. 2014. PMID: 24409199 Free PMC article. Review.
-
Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy.Proc Natl Acad Sci U S A. 1990 May;87(9):3309-13. doi: 10.1073/pnas.87.9.3309. Proc Natl Acad Sci U S A. 1990. PMID: 2333285 Free PMC article.
-
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.Clin Cancer Res. 2016 Jan 15;22(2):310-8. doi: 10.1158/1078-0432.CCR-15-1412. Epub 2015 Sep 8. Clin Cancer Res. 2016. PMID: 26350263 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical